Sutro Biopharma Inc (NASDAQ:STRO) has prioritized three wholly owned pre-clinical programs in its next-generation ADC pipeline, indicating a focused strategic direction. The company's cash runway ...

Sutro Biopharma (NASDAQ:STRO) fell ~14% in the premarket on Friday ... leading to multiple downgrades on Wall Street. The South San Francisco, California-based biotech attributed the decision ...

Sutro Biopharma, Inc. (STRO) came out with a quarterly loss of $0.89 per share versus the Zacks Consensus Estimate of a loss of $0.86. This compares to earnings of $0.42 per share a year ago.

Sutro Biopharma (NASDAQ:STRO) said on Thursday that, under its portfolio review, the company has decided to advance its dual-payload ADC programs, while deprioritizing development of luveltamab ...

In a report released today, Asthika Goonewardene from Truist Financial maintained a Buy rating on Sutro Biopharma (STRO – Research Report). The company’s shares closed yesterday at $1.25.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sutro Biopharma (STRO – Research Report) and Generation Bio (GBIO – Research Report).

It's easy to use Dollar Tree plastic straws to create customized wall art to suit any style, whether you want something ...

But if you hang a gallery wall incorrectly, it can look wrong and even "cheapen" your space, according to TikToker Brittany, ...

Construction continued up to the Ming dynasty (1368–1644), when the Great Wall became the world's largest military structure. Its historic and strategic importance is matched only by its architectural ...